152 related articles for article (PubMed ID: 19176353)
41. Electroacupuncture alters the expression of genes associated with lipid metabolism and immune reaction in liver of hypercholesterolemia mice.
Kang Y; Li M; Yan W; Li X; Kang J; Zhang Y
Biotechnol Lett; 2007 Dec; 29(12):1817-24. PubMed ID: 17704895
[TBL] [Abstract][Full Text] [Related]
42. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia.
Yao JK; Thomas EA; Reddy RD; Keshavan MS
Schizophr Res; 2005 Jan; 72(2-3):259-66. PubMed ID: 15560970
[TBL] [Abstract][Full Text] [Related]
43. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease.
Bhatia S; Knoch B; Wong J; Kim WS; Else PL; Oakley AJ; Garner B
Biochem J; 2012 Mar; 442(3):713-21. PubMed ID: 22150111
[TBL] [Abstract][Full Text] [Related]
44. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.
Hunter S; Weiss S; Ou CY; Jaye D; Young A; Wilcox J; Arbiser JL; Monson D; Goldblum J; Nolen JD; Varma V
Hum Pathol; 2005 Sep; 36(9):987-93. PubMed ID: 16153462
[TBL] [Abstract][Full Text] [Related]
45. Production of a soluble and functional recombinant apolipoproteinD in the Pichia pastoris expression system.
Armanmehr S; Kalhor HR; Tabarraei A
Protein Expr Purif; 2016 May; 121():157-62. PubMed ID: 26826316
[TBL] [Abstract][Full Text] [Related]
46. Obesity alters circadian expressions of molecular clock genes in the brainstem.
Kaneko K; Yamada T; Tsukita S; Takahashi K; Ishigaki Y; Oka Y; Katagiri H
Brain Res; 2009 Mar; 1263():58-68. PubMed ID: 19401184
[TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein D Internalization Is a Basigin-dependent Mechanism.
Najyb O; Brissette L; Rassart E
J Biol Chem; 2015 Jun; 290(26):16077-87. PubMed ID: 25918162
[TBL] [Abstract][Full Text] [Related]
48. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
49. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes.
Kobayashi H; Matsuda M; Fukuhara A; Komuro R; Shimomura I
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1326-34. PubMed ID: 19366877
[TBL] [Abstract][Full Text] [Related]
50. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D.
Patel SC; Asotra K; Patel YC; McConathy WJ; Patel RC; Suresh S
Neuroreport; 1995 Mar; 6(4):653-7. PubMed ID: 7605920
[TBL] [Abstract][Full Text] [Related]
51. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.
Neyrinck AM; Cani PD; Dewulf EM; De Backer F; Bindels LB; Delzenne NM
Biochem Biophys Res Commun; 2009 Jul; 385(3):351-6. PubMed ID: 19463788
[TBL] [Abstract][Full Text] [Related]
52. Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis.
Chen H; Li Y; Du J; Cao Y; Li X
Mol Cell Biochem; 2011 Aug; 354(1-2):311-6. PubMed ID: 21526344
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein D--an atypical apolipoprotein.
Weech PK; Provost P; Tremblay NM; Camato RN; Milne RW; Marcel YL; Rassart E
Prog Lipid Res; 1991; 30(2-3):259-66. PubMed ID: 1823944
[TBL] [Abstract][Full Text] [Related]
54. [The involvement of apolipoprotein D in pathologies affecting the nervous system].
Navarro-Incio AM; Tolivia-Fernández J
Rev Neurol; 2004 Jun 16-30; 38(12):1166-75. PubMed ID: 15229832
[TBL] [Abstract][Full Text] [Related]
55. Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction.
Kurano M; Tsukamoto K; Kamitsuji S; Kamatani N; Hasegawa K; Hara M; Ishikawa T; Yatomi Y; Teramoto T
Inflamm Res; 2023 Feb; 72(2):263-280. PubMed ID: 36536251
[TBL] [Abstract][Full Text] [Related]
56. Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions.
Li H; Ruberu K; Karl T; Garner B
PLoS One; 2016; 11(2):e0148238. PubMed ID: 26829325
[TBL] [Abstract][Full Text] [Related]
57. Increased intrathecal production of apolipoprotein D in multiple sclerosis.
Reindl M; Knipping G; Wicher I; Dilitz E; Egg R; Deisenhammer F; Berger T
J Neuroimmunol; 2001 Oct; 119(2):327-32. PubMed ID: 11585636
[TBL] [Abstract][Full Text] [Related]
58. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.
Thomas EA; Dean B; Pavey G; Sutcliffe JG
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4066-71. PubMed ID: 11274430
[TBL] [Abstract][Full Text] [Related]
59. Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis.
Sánchez D; Ganfornina MD; Martínez S
Mech Dev; 2002 Jan; 110(1-2):225-9. PubMed ID: 11744388
[TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein D in Oxidative Stress and Inflammation.
Fyfe-Desmarais G; Desmarais F; Rassart É; Mounier C
Antioxidants (Basel); 2023 Apr; 12(5):. PubMed ID: 37237893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
